Cited by 248Oral Health Pathology and TreatmentHead and Neck Cancer StudiesHIV/AIDS oral health manifestations

The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.

Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory

Dionne, Kalen R., Warnakulasuriya, Saman, Binti Zain, Rosnah, Cheong, Sok Ching·2015·International Journal of Cancer

Open this paper in CoChat — free account

Abstract

Despite commendable progress in the prevention, detection, and treatment of a wide variety of solid tumor types, oral squamous cell carcinoma (OSCC) remains a significant health burden across the globe. OSCC carcinogenesis involves accumulation of genetic alterations that coincide with the multistep malignant transformation of normal oral epithelium. OSCC is often first diagnosed at late stages of the disease (advanced regional disease and/or metastasis). Delayed diagnosis precludes successful treatment and favorable outcomes. In clinical practice, opportunities exist to identify patients with oral potentially malignant disorders (OPMDs), which precede the development of cancer. This review addresses the current status of laboratory and clinical research on OPMDs, with emphasis on leukoplakia and erythroplakia. OSF is also presented, though there is a paucity of published studies on this disorder. We focus on findings that could translate into earlier diagnosis and more efficacious treatment of those lesions with significant malignant potential. We explore how markers of OPMD malignant transformation might be implemented into current diagnostic practice to help clinicians objectively stratify patients into treatment/follow‐up groups according to relative risk. We provide an overview of recently concluded and ongoing OPMD chemoprevention trials. We describe laboratory OPMD models that can be used to not only to reveal the genetic and molecular intricacies of oral cancer but also to develop novel screening methods and therapeutic approaches. Finally, we call for targeted screening programs of at‐risk populations in order to facilitate diagnosis and treatment of OPMD and early OSCC.

Integrity signals

Registry

Crossref · 10.1002/ijc.28754

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global cancer statistics
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,710
Cancer Statistics, 2010
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
The molecular biology of head and neck cancer
Leemans, C. R., Braakhuis, B. J. M., & Brakenhoff, R. H. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2982 · Cited by 2,640
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.
Cheng, A., Hsu, C., Lin, J., Hsu, M. M., Ho, Y., Shen, T. S., Ko, J. Y., Lin, J.-T., Lin, B., Ming-Shiang, W., et al. (2001) · PubMed · Cited by 2,071
Nomenclature and classification of potentially malignant disorders of the oral mucosa
Warnakulasuriya, S., Johnson, N. W., & van der Waal, I. (2007) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00582.x · Cited by 1,804
Self-citation
Genetic progression model for head and neck cancer: implications for field cancerization.
Califano, J. A., van der Riet, P., Westra, W. H., Nawroz, H., Clayman, G. L., Piantadosi, S., Corio, R. L., Lee, D. J., Greenberg, B. M., Koch, W. M., et al. (1996) · PubMed · Cited by 1,355
Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study
Herrero, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg107 · Cited by 1,230
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,141
Recent Advances in Head and Neck Cancer
Haddad, R. I., & Shin, D. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707975 · Cited by 918
13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia
Hong, W. K., Endicott, J., Itri, L. M., Doos, W. G., Batsakis, J. G., Bell, R. H., Fofonoff, S. A., Byers, R., Atkinson, E. N., Vaughan, C. W., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612113152401 · Cited by 811
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Liu, X., Ory, V., Chapman, S., Yuan, H., Albanese, C., Kallakury, B., Timofeeva, O. A., Nealon, C., Dakic, A., Simic, V., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.036 · Cited by 726
Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement
Warnakulasuriya, S., Reibel, J., Bouquot, J. E., & Dabelsteen, E. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00584.x · Cited by 652
Self-citation
Natural history of potentially malignant oral lesions and conditions: an overview of the literature
Napier, S. S., & Speight, P. M. (2007) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00579.x · Cited by 622
P rognosis of O ral P re-malignant L esions: S ignificance of C linical, H istopathological, and M olecular B iological C haracteristics
Reibel, J. (2003) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130301400105 · Cited by 552
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity
Gillison, M. L. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.011 · Cited by 549
Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment
Mao, L., Lee, J. S., Fan, Y. H., Ro, J. Y., Batsakis, J. G., Lippman, S. M., Hittelman, W., & Hong, W. K. (1996) · Nature Medicine · doi:10.1038/nm0696-682 · Cited by 526
Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation
Kujan, O., Oliver, R., Khattab, A., Roberts, S. A., Thakker, N., & Sloan, P. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2005.12.014 · Cited by 486
Long-term treatment outcome of oral premalignant lesions
Holmstrup, P., Vedtofte, P., Reibel, J., & Stoltze, K. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2005.08.011 · Cited by 444
Treatment and follow‐up of oral dysplasia — A systematic review and meta‐analysis
Mehanna, H. M., Rattay, T., Smith, J. A., & McConkey, C. C. (2009) · Head & Neck · doi:10.1002/hed.21131 · Cited by 427
Predicting cancer development in oral leukoplakia: ten years of translational research.
Lee, J. J., Hong, W. K., Hittelman, W. N., Mao, L., Lotan, R., Shin, D. M., Benner, S. E., Xu, X. C., Lee, J. S., Papadimitrakopoulou, V., et al. (2000) · PubMed · Cited by 425
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
Rosin, M. P., Cheng, X., Poh, C. F.-Y., Lam, W. L., Huang, Y., Lovas, J. G. L., Berean, K. W., Epstein, J. B., Priddy, R., Le, N. D., et al. (2000) · PubMed · Cited by 424
Podoplanin: emerging functions in development, the immune system, and cancer
Astarita, J. L., Acton, S. E., & Turley, S. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00283 · Cited by 411
Pooled estimate of world leukoplakia prevalence: a systematic review
Petti, S. (2003) · Oral Oncology · doi:10.1016/s1368-8375(03)00102-7 · Cited by 406
Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin
Lotan, R., Xu, X., Lippman, S. M., Ro, J. Y., Lee, J. S., Lee, J. J., & Hong, W. K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322103 · Cited by 405
Comparison of Low-Dose Isotretinoin with Beta Carotene to Prevent Oral Carcinogenesis
Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H., & Hong, W. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280103 · Cited by 401
Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands
Schepman, K. P., van der Meij, E. H., Smeele, L. E., & van der Waal, I. (1998) · Oral Oncology · doi:10.1016/s1368-8375(98)80007-9 · Cited by 384
Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement
Henning, S. M., Niu, Y., Lee, N. H., Thames, G., Minutti, R. R., Wang, H., Go, V. L. W., & Heber, D. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1558 · Cited by 342
Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia
Abbey, L. M., Kaugars, G. E., Gunsolley, J. C., Burns, J. C., Page, D. G., Svirsky, J. A., Eisenberg, E., Krutchkoff, D. J., & Cushing, M. (1995) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/s1079-2104(05)80201-x · Cited by 311
Epithelial to mesenchymal transition (EMT) biomarkers – E-cadherin, beta-catenin, APC and Vimentin – in oral squamous cell carcinogenesis and transformation
Chaw, S., AbdulMajeed, A. A., Dalley, A. J., Chan, A., Stein, S. R., & Farah, C. S. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.05.011 · Cited by 303
4-Nitroquinoline-1-oxide induced experimental oral carcinogenesis
Kanojia, D., & Vaidya, M. M. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2005.10.013 · Cited by 291
Update on Oral Epithelial Dysplasia and Progression to Cancer
Speight, P. M. (2007) · Head and Neck Pathology · doi:10.1007/s12105-007-0014-5 · Cited by 275
Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta‐carotene and with beta‐carotene plus vitamin A
STICH, H. F., Rosin, M. P., Hornby, A. P., Mathew, B., Sankaranarayanan, R., & Nair, M. K. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420209 · Cited by 266
Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: An attempt to understand the sources of variation
Kujan, O., Khattab, A., Oliver, R., Roberts, S. A., Thakker, N., & Sloan, P. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.03.009 · Cited by 262
Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management
van der Waal, I. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.02.016 · Cited by 260
Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions
Tsao, A. S., Liu, D., Martin, J. W., Tang, X.-M., Lee, J. J., El‐Naggar, A. K., Wistuba, I. I., Culotta, K. S., Mao, L., Gillenwater, A. M., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0121 · Cited by 256
Observer variability in the histologic assessment of oral premalignant lesions
Karabulut, A., Reibel, J., Therkildsen, M. H., Praetorius, F., Nielsen, H. W., & Dabelsteen, E. (1995) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1995.tb01166.x · Cited by 248
Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England
Warnakulasuriya, S., Kovacevic, T., Madden, P. B., Coupland, V. H., Sperandio, M., Odell, E. W., & Møller, H. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01054.x · Cited by 243
Self-citation
Cell Cycle Dysregulation by Green Tea Polyphenol Epigallocatechin-3-Gallate
Ahmad, N., Cheng, P., & Mukhtar, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3297 · Cited by 225
Environmental factors in cancer of the larynx.A second look
Wynder, E. L., Covey, L. S., Mabuchi, K., & Mushinski, M. H. (1976) · Cancer · doi:10.1002/1097-0142(197610)38:4 · Cited by 220
A systematic review of medical interventions for oral submucous fibrosis and future research opportunities
Kerr, A., Warnakulasuriya, S., Mighell, A. J., Dietrich, T., Nasser, M., Rimal, J., Jalil, A. A., Bornstein, M. M., Nagao, T., Fortune, F., et al. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01791.x · Cited by 217
Self-citation
Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India
Mehta, F. S., Pindborg, J. J., Gupta, P., Daftary, D. K., & Odont (1969) · Cancer · doi:10.1002/1097-0142(196910)24:4 · Cited by 217
Head and Neck Tumours
Spiessl, B., Scheibe, O., & Wagner, G. (1982) · Springer eBooks · doi:10.1007/978-3-662-02340-2_1 · Cited by 215
Immortalization of normal human oral keratinocytes with type 16 human papillomavirus
Park, N., Min, B.-M., Li, S., Huang, M. Z., & Doniger, J. (1991) · Carcinogenesis · doi:10.1093/carcin/12.9.1627 · Cited by 212
Loss of Heterozygosity (LOH) Profiles—Validated Risk Predictors for Progression to Oral Cancer
Zhang, L., Poh, C. F.-Y., Williams, M., Laronde, D. M., Berean, K. W., Gardner, P. J., Jiang, H., Wu, L., Lee, J. J., & Rosin, M. P. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0173 · Cited by 212
Podoplanin: A Novel Marker for Oral Cancer Risk in Patients With Oral Premalignancy
Kawaguchi, H., El‐Naggar, A. K., Papadimitrakopoulou, V., Ren, H., Fan, Y.-H., Feng, L., Lee, J. J., Kim, E. J.-H., Hong, W. K., Lippman, S. M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.4072 · Cited by 210
Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses
Awan, K. H., Morgan, P. R., & Warnakulasuriya, S. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.02.001 · Cited by 204
Self-citation
Intercountry prevalences and practices of betel‐quid use in south, southeast and eastern asia regions and associated oral preneoplastic disorders: An international collaborative study by asian betel‐quid consortium of south and east Asia
Lee, C., Ko, A. M., Warnakulasuriya, S., Yin, B., Sunarjo, Zain, R. B., Ibrahim, S. O., Liu, Z., Li, W., Zhang, S., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25809 · Cited by 195
Self-citation
Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma
Pindborg, J. J., Reibel, J., & Holmstrup, P. (1985) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1985.tb00549.x · Cited by 187
Response of oral leukoplakias to the administration of vitamin A
STICH, H. F., Hornby, A. P., Mathew, B., Sankaranarayanan, R., & Nair, M. (1988) · Cancer Letters · doi:10.1016/0304-3835(88)90266-2 · Cited by 183
Oral premalignant lesions: is a biopsy reliable?
Holmstrup, P., Vedtofte, P., Reibel, J., & Stoltze, K. (2007) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00513.x · Cited by 178
Understanding Carcinogenesis for Fighting Oral Cancer
Tanaka, T., & Ishigamori, R. (2011) · Journal of Oncology · doi:10.1155/2011/603740 · Cited by 178
A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization.
Partridge, M., Pateromichelakis, S., Phillips, E., Emilion, G., A’Hern, R., & Langdon, J. (2000) · PubMed · Cited by 176
Ablation of either p21 or Bax prevents p53‐dependent apoptosis induced by green tea polyphenol epigallocatechin‐3‐gallate
Hastak, K., Agarwal, M. K., Mukhtar, H., & Agarwal, M. L. (2005) · The FASEB Journal · doi:10.1096/fj.04-2226fje · Cited by 171
Management of potentially malignant disorders: evidence and critique
Lodi, G., & Porter, S. R. (2007) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00575.x · Cited by 170
A national epidemiological survey of oral mucosal lesions in Malaysia
Zain, R. B., Ikeda, N., Razak, I. A., Axéll, T., Majid, Z. A., Gupta, P. C., & Yaacob, M. (1997) · Community Dentistry And Oral Epidemiology · doi:10.1111/j.1600-0528.1997.tb00959.x · Cited by 169
Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy
Mao, L., Papadimitrakopoulou, V., Shin, D. M., Fan, Y.-H., Zhou, X., Lee, J. S., Hong, W. K., El‐Naggar, A. K., Shin, H., Clayman, G. L., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.20.1545 · Cited by 166
Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment
Sankaranarayanan, R., Mathew, B., Varghese, C. V., Sudhakaran, P. R., Menon, V. P., Jayadeep, A., Nair, M. K., Mathews, C., Mahalingam, T. R., Balaram, P., et al. (1997) · Oral Oncology · doi:10.1016/s0964-1955(97)00010-9 · Cited by 164
Gene Expression Profiling Predicts the Development of Oral Cancer
Saintigny, P., Zhang, L., Fan, Y.-H., El‐Naggar, A. K., Papadimitrakopoulou, V. A., Feng, L., Lee, J. J., Kim, E. S., Hong, W. K., & Mao, L. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0155 · Cited by 143
Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model
Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A. A., & Gutkind, J. S. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0147 · Cited by 140
Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial.
Armstrong, W. B., Kennedy, A. R., Wan, X. S., Taylor, T. H., Nguyen, Q. A., Jensen, J., Thompson, W., Lagerberg, W., & Meyskens, F. L. (2000) · PubMed · Cited by 137
Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft Model
Zhang, X., Chen, Z., Choe, M. S., Lin, Y., Sun, S., Wieand, H. S., Shin, H. J. C., Chen, A., Khuri, F. R., & Shin, D. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2102 · Cited by 133
Overexpression of 5-Lipoxygenase and Cyclooxygenase 2 in Hamster and Human Oral Cancer and Chemopreventive Effects of Zileuton and Celecoxib
Li, N., Sood, S., Wang, S., Fang, M., Wang, P., Sun, Z., Yang, C. S., & Chen, X. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1684 · Cited by 124
DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression
Torres-Rendon, A., Stewart, R. L., Craig, G. T., Wells, M. L., & Speight, P. M. (2008) · Oral Oncology · doi:10.1016/j.oraloncology.2008.07.006 · Cited by 123
Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck
Sacks, P. G. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00049486 · Cited by 122
Predictive Value of Dysplasia Grading and DNA Ploidy in Malignant Transformation of Oral Potentially Malignant Disorders
Sperandio, M., Brown, A. L., Lock, C., Morgan, P. R., Coupland, V. H., Madden, P. B., Warnakulasuriya, S., Møller, H., & Odell, E. W. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0001 · Cited by 121
Self-citation
Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor, F., Muntoni, A., Fleming, J., Brown, J. E., Felix, D. H., MacDonald, D. G., Parkinson, E. K., & Harrison, P. R. (2002) · PubMed · Cited by 120
Cancer epidemiology in South Asia - past, present and future.
Moore, M. A., Ariyaratne, Y., Badar, F., Bhurgri, Y., Datta, K., Mathew, A., Gangadharan, P., Nandakumar, A., Pradhananga, K. K., Talukder, M. H., et al. (2010) · PubMed · Cited by 120
Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility
Fleskens, S. A. J. H. M., & Slootweg, P. J. (2009) · Head & Neck Oncology · doi:10.1186/1758-3284-1-11 · Cited by 119
Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
Armstrong, W. B., Kennedy, A. R., Wan, X. S., Atiba, J. O., McLaren, C. E., & Meyskens, F. L. (2000) · PubMed · Cited by 114
Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant Lesions
Papadimitrakopoulou, V. A., William, W. N., Dannenberg, A. J., Lippman, S. M., Lee, J. J., Ondrey, F. G., Peterson, D. E., Feng, L., Atwell, A., El‐Naggar, A. K., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4024 · Cited by 114
Potentially malignant oral lesions in Northern Ireland: a 20‐year population‐based perspective of malignant transformation
Cowan, C. G., Gregg, T. A., Napier, S., McKenna, S., & Kee, F. (2001) · Oral Diseases · doi:10.1034/j.1601-0825.2001.70104.x · Cited by 112
Betel-quid chewing with or without tobacco is a major risk factor for oral potentially malignant disorders in Sri Lanka: A case-control study
Amarasinghe, H. K., Usgodaarachchi, U. S., Johnson, N. W., Lalloo, R., & Warnakulasuriya, S. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.01.017 · Cited by 111
Self-citation
Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis.
Roz, L., Wu, C. L., Porter, S. R., Scully, C. M., Speight, P. M., Read, A., Sloan, P., & Thakker, N. (1996) · PubMed · Cited by 104
Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia
Mulshine, J. L., Atkinson, J. C., Greer, R. O., Papadimitrakopoulou, V. A., Waes, C. V., Rudy, S., Martin, J. W., Steinberg, S. M., Liewehr, D. J., Avis, I. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1020-3 · Cited by 104
Alterations of Rb Pathway Components Are Frequent Events in Patients with Oral Epithelial Dysplasia and Predict Clinical Outcome in Patients with Squamous Cell Carcinoma
Soni, S., Kaur, J., Kumar, A., Chakravarti, N., Mathur, M., Bahadur, S., Shukla, N. K., Deo, S. V. S., & Ralhan, R. (2005) · Oncology · doi:10.1159/000086970 · Cited by 99
Expression of FAS (CD95/APO-1) and FAS ligand in lung cancer, its prognostic and predictive relevance
gi, R. K., & Volm, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990621)84:3 · Cited by 99
Randomized Trial of 13-cis Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral Premalignancy
Papadimitrakopoulou, V. A., Lee, J. J., William, W. N., Martin, J. W., Thomas, M., Kim, E. S., Khuri, F. R., Shin, D. M., Feng, L., Hong, W. K., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1850 · Cited by 98
Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma
Bradley, G., Odell, E. W., Raphael, S. J., Ho, J., Le, L. W., Benchimol, S., & Kamel‐Reid, S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605905 · Cited by 96
Low-Dose Isotretinoin Versus -Carotene to Prevent Oral Carcinogenesis: Long-term Follow-up
Papadimitrakopoulou, V. A., Hong, W. K., Lee, J. S., Lippman, S. M., Martin, J. W., Lee, J. J., & Batsakis, J. G. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.257 · Cited by 94
Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity
Shintani, S., Mihara, M., Nakahara, Y., Kiyota, A., Ueyama, Y., Matsumura, T., & Wong, D. T. (2002) · Oral Oncology · doi:10.1016/s1368-8375(01)00048-3 · Cited by 93
Autofluorescence imaging of potentially malignant mucosa lesions
Scheer, M., Neugebauer, J., Derman, A., Fuss, J., Drebber, U., & Zöeller, J. E. (2011) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2010.12.010 · Cited by 92
Oral leukoplakia in relation to tobacco habits
Mehta, F. S., Shroff, B. C., Gupta, P., & Daftary, D. K. (1972) · Oral Surgery Oral Medicine Oral Pathology · doi:10.1016/0030-4220(72)90319-2 · Cited by 91
Chemical Carcinogenesis Models for Evaluating Molecular-Targeted Prevention and Treatment of Oral Cancer
Vitale-Cross, L. A., Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A., & Gutkind, J. S. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0058 · Cited by 90
Prognostic value of DNA ploidy status in patients with oral leukoplakia
Bremmer, J. F., Brakenhoff, R. H., Broeckaert, M. A. M., Beliën, J. A. M., Leemans, C. R., Bloemena, E., van der Waal, I., & Braakhuis, B. J. M. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.07.025 · Cited by 89
Upregulation of HIF‐1α in malignant transformation of oral submucous fibrosis
Tilakaratne, W. M., Iqbal, Z., Teh, M., Ariyawardana, A., Pitiyage, G. N., Cruchley, A. T., Stewart, J. E., Hagi‐Pavli, E., Lalli, A., Waseem, A., et al. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00625.x · Cited by 87
DNA ploidy in proliferative verrucous leukoplakia
Klanrit, P., Sperandio, M., Brown, A. L., Shirlaw, P., Challacombe, S., Morgan, P. R., & Odell, E. W. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.03.016 · Cited by 87
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
Papadimitrakopoulou, V. A., Izzo, J. G., Mao, L., Keck, J. M., Hamilton, D., Shin, D. M., El‐Naggar, A. K., den Hollander, P., Liu, D., Hittelman, W. N., et al. (2001) · PubMed · Cited by 87
Instability of chromosome structure in cancer cells increases exponentially with degrees of aneuploidy
Fabarius, A. C., Hehlmann, R., & DUESBERG, P. H. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00003-7 · Cited by 86
4NQO oral carcinogenesis: animal models, molecular markers and future expectations
Vered, M., Yarom, N., & Dayan, D. (2004) · Oral Oncology · doi:10.1016/j.oraloncology.2004.07.005 · Cited by 85
Osseous metastases of breast cancer. Clinical, biochemical, radiographic, and scintigraphic evaluation of response to therapy
Hortobágyi, G. N., Libshitz, H. I., & Seabold, J. E. (1984) · Cancer · doi:10.1002/1097-0142(19840201)53:3 · Cited by 83
p53 expression in oral precancer as a marker for malignant potential
Murti, P. R., Warnakulasuriya, S., Johnson, N. W., Bhonsle, R. B., Gupta, P., Daftary, D. K., & Mehta, F. S. (1998) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1998.tb01940.x · Cited by 82
Self-citation
Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias
Nasser, W., Flechtenmacher, C., Holzinger, D., Hofele, C., & Bosch, F. X. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01026.x · Cited by 81
Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses
Awan, K. H., Morgan, P. R., & Warnakulasuriya, S. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01048.x · Cited by 78
Self-citation
High prevalence of p16 genetic alterations in head and neck tumours
Miracca, E. C., Kowalski, L. P., & Nagai, M. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690747 · Cited by 78
Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions
Massi, D., Franchi, A., Sardi, I., Magnelli, L., Paglierani, M., Borgognoni, L., Reali, U. M., & Santucci, M. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200106)194:2 · Cited by 76
Diagnosis of oral precancer with optical coherence tomography
Lee, C., Chi, T., Wu, C.-T., Tsai, M., Chiang, C., & Yang, C. C. C.-C. (2012) · Biomedical Optics Express · doi:10.1364/boe.3.001632 · Cited by 74
Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity.
Liu, S. C., Sauter, E. R., Clapper, M. L., Feldman, R. S., Levin, L., Chen, S.-Y., Yen, T. J., Ross, E. A., Engstrom, P. F., & Klein–Szanto, A. J. (1998) · PubMed · Cited by 70
Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions
Turatti, E., Neves, A. D. C., Gallottini, M. H. C., & de Sousa, S. O. M. (2005) · Journal of Oral Science · doi:10.2334/josnusd.47.71 · Cited by 70
Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias
Rousseau, A. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00114-7 · Cited by 70
Inhibition of EGFR-STAT3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma
Leeman‐Neill, R. J., Seethala, R. R., Singh, S. V., Freilino, M. L., Bednash, J. S., Thomas, S. M., Panahandeh, M. C., Gooding, W. E., Joyce, S. C., Lingen, M. W., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0249 · Cited by 70
Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
Bhattacharya, A., Roy, R., Snijders, A. M., Hamilton, G., Paquette, J., Tokuyasu, T. A., Bengtsson, H. L., Jordan, R. C., Olshen, A. B., Pinkel, D., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1944 · Cited by 70
Understanding the biology of oral cancer.
Das, B. R., & Nagpal, J. K. (2002) · PubMed · Cited by 69
Use of Lugol’s iodine in oral cancer diagnosis: An overview
Petruzzi, M., Lucchese, A., Baldoni, E., Grassi, F. R., & Serpico, R. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.07.013 · Cited by 68
Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity – a clinical and histological assessment
Awan, K. H., Yang, Y., Pr, M., & Warnakulasuriya, S. (2012) · Oral Diseases · doi:10.1111/j.1601-0825.2012.01935.x · Cited by 67
Self-citation
Molecular Alterations in Oral Carcinogenesis: Significant Risk Predictors in Malignant Transformation and Tumor Progression
Shah, N. G., Trivedi, T. I., Tankshali, R. A., Goswami, J., Shah, J., Jetly, D., Kobawala, T. P., Patel, K. C., Shukla, S. N., Shah, P. M., et al. (2007) · The International Journal of Biological Markers · doi:10.5301/jbm.2008.4745 · Cited by 67
Incidence rates for oral leukoplakia and lichen planus in a Japanese population
Nagao, T., Ikeda, N., Fukano, H., Hashimoto, S., Shimozato, K., & Warnakulasuriya, S. (2005) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2005.00349.x · Cited by 64
Self-citation
ABT-510 Is an Effective Chemopreventive Agent in the Mouse 4-Nitroquinoline 1-Oxide Model of Oral Carcinogenesis
Hasina, R., Martin, L. E., Kasza, K., Jones, C. L., Jalil, A., & Lingen, M. W. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0211 · Cited by 63
Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
Lotan, R. (1996) · PubMed · Cited by 63
Role of ΔNp63γ in Epithelial to Mesenchymal Transition
Lindsay, J., McDade, S. S., Pickard, A., McCloskey, K. D., & McCance, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162511 · Cited by 62
ΔNp63α Protein Triggers Epithelial-Mesenchymal Transition and Confers Stem Cell Properties in Normal Human Keratinocytes
Oh, J.-E., Kim, R. H., Shin, K.-H., Park, N., & Kang, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244939 · Cited by 62
Evaluation comparing multiple treatments with a 2-msec and 10-msec alexandrite laser for hair removal
Goldberg, D. J., & Ahkami, R. (1999) · Lasers in Surgery and Medicine · doi:10.1002/(sici)1096-9101(1999)25:3 · Cited by 62
Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis.
Kotelnikov, V. M., Coon, J. S., Mundle, S. D., Kelanic, S., LaFollette, S., S, I. V. T., Hutchinson, J. C., Panje, W. R., Caldarelli, D. D., & Preisler, H. D. (1997) · PubMed · Cited by 61
Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma
Abbas, N. F., El-Sharkawy, S. L., Abbas, E. A., & El‐Shaer, M. A. (2006) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2005.11.008 · Cited by 58
Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype.
McGregor, F., Wagner, E., Felix, D. H., Soutar, D. S., Parkinson, K., & Harrison, P. R. (1997) · PubMed · Cited by 53
Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: a potential new model for oral cancer
Guttenplan, J. B., Kosinska, W., Zhao, Z., Chen, K., Aliaga, C. A., DelTondo, J., Cooper, T. K., Sun, Y., Zhang, S., Jiang, K., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26344 · Cited by 53
Combined Targeting of the Epidermal Growth Factor Receptor and Cyclooxygenase-2 Pathways
Lippman, S. M., Gibson, N. W., Subbaramaiah, K., & Dannenberg, A. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1217 · Cited by 53
Oral leukoplakia and erythroplakia: a review and update.
Bouquot, J. E. (1994) · PubMed · Cited by 50
Development of an in vivo mouse model to study oral submucous fibrosis
Perera, S., Gunasinghe, D., Perera, P. A. J., Ranasinghe, A. W., Amaratunga, P., Warnakulasuriya, S., & Kaluarachchi, K. (2007) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00523.x · Cited by 49
Self-citation
Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression
Mishra, R., & Das, B. R. (2009) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2009.07.003 · Cited by 49
Diagnostic significance of narrow‐band imaging for detecting high‐grade dysplasia, carcinoma in situ, and carcinoma in oral leukoplakia
Yang, S., Lee, Y., Chang, L., Hwang, C., & Chen, T. (2012) · The Laryngoscope · doi:10.1002/lary.23629 · Cited by 49
Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression
Das, R. K., Pal, M., Barui, A., Paul, R. R., Chakraborty, C., Ray, A. K., Sengupta, S., & Chatterjee, J. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.078964 · Cited by 48
Frequent gene deletions in potentially malignant oral lesions
Emilion, G., Langdon, J., Speight, P. M., & Partridge, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.142 · Cited by 47
Excision-Repair of 4-Nitroquinoline-1-oxide Damage Responsible for Killing, Mutation, and Cancer
Ikenaga, M., Ishii, Y., Tada, M., Kakunaga, T., Takebe, H., & Kondo, S. (1975) · Springer eBooks · doi:10.1007/978-1-4684-2898-8_54 · Cited by 47
Podoplanin expression during dysplasia–carcinoma sequence in the oral cavity
Inoue, H., Miyazaki, Y., Kikuchi, K., Yoshida, N., Ide, F., Ohmori, Y., Tomomura, A., Sakashita, H., & Kusama, K. (2011) · Tumor Biology · doi:10.1007/s13277-011-0261-7 · Cited by 44
Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
Raju, B., Mehrotra, R., Øijordsbakken, G., Al-Sharabi, A. K., Vasstrand, E. N., & Ibrahim, S. O. (2005) · PubMed · Cited by 43
DNA cytometry of oral leukoplakia and oral lichen planus.
Femiano, F., & Scully, C. M. (2005) · PubMed · Cited by 43
Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications
Kreppel, M., Kreppel, B., Drebber, U., Wedemayer, I., Rothamel, D., Zöller, J., & Scheer, M. (2012) · Oral Diseases · doi:10.1111/j.1601-0825.2012.01927.x · Cited by 40
Mutagenesis induced by oral carcinogens in lacZ mouse (Muta™Mouse) tongue and other oral tissues
von Pressentin, M. D. M., Kosinska, W., & Guttenplan, J. B. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2167 · Cited by 38
Prognostic value of cyclin D1, p27, and p63 in oral leukoplakia
Kövesi, G., & Szende, B. (2006) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2006.00396.x · Cited by 37
Forty years of monitoring head and neck cancer in Norway--no good news.
Mork, J. (1999) · PubMed · Cited by 37
Unique FISH Patterns Associated with Cancer Progression of Oral Dysplasia
Poh, C. F.-Y., Zhu, Y., Chen, E., Berean, K. W., Wu, L., Zhang, L., & Rosin, M. P. (2011) · Journal of Dental Research · doi:10.1177/0022034511425676 · Cited by 35
Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development
Feng, J., Mi, J.-G., Wu, L., Ma, L., Shi, L., Yang, X., Liu, W., Zhang, C., & Zhou, Z. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.03.015 · Cited by 35
Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas
Ohta (2010) · Oncology Reports · doi:10.3892/or_00000822 · Cited by 34
Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes.
Loughran, Ö., Edington, K. G., Berry, I. J., Clark, L., & Parkinson, E. K. (1994) · PubMed · Cited by 33
Increased expression of cyclooxygenase (COX)‐2 in DMBA‐induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX‐2 inhibitor celecoxib
Nishimura, N., Urade, M., Hashitani, S., Noguchi, K., Manno, Y., Takaoka, K., & Sakurai, K. (2004) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2004.00254.x · Cited by 32
The p53 status of cultured human premalignant oral keratinocytes
Burns, J. E., Clark, L., Yeudall, W. A., Mitchell, R. T., Mackenzie, K., Chang, S., & Parkinson, E. K. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.356 · Cited by 32
p53 Haploinsufficiency Profoundly Accelerates the Onset of Tongue Tumors in Mice Lacking the Xeroderma Pigmentosum Group A Gene
Ide, F., Kitada, M., Sakashita, H., Kusama, K., Tanaka, K., & Ishikawa, T. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63531-6 · Cited by 32
A follow up study of oral cancer and precancerous lesions in 57,518 industrial workers of Gujarat, India.
Bhargava, K., Smith, L. W., Nj, M., Silverman, S., Malaowalla, A. M., & Kf, B. (1975) · PubMed · Cited by 32
Tobacco use increase the number of aneuploid nuclei in the clinically healthy oral epithelium
Souto, G. R., Caliari, M. V., Lins, C. E. C., de Aguiar, M. C. F., de Abreu, M. H. N. G., & Mesquita, R. A. (2010) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2010.00907.x · Cited by 31
Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies
Ishikawa, T., Ide, F., Qin, X., Zhang, S., Takahashi, Y., Sekiguchi, M., Tanaka, K., & Nakatsuru, Y. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00094-x · Cited by 30
Squamous cell carcinoma and precursor lesions: prevention
Warnakulasuriya, S. (2011) · Periodontology 2000 · doi:10.1111/j.1600-0757.2011.00395.x · Cited by 29
Self-citation
Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO
Kim, M. M., Glazer, C. A., Mambo, E., Chatterjee, A., Zhao, M., Sidransky, D., & Califano, J. A. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2005.07.004 · Cited by 29
DNA content as a prognostic marker of oral lichen planus with a risk of cancer development.
Mattila, R., Alanen, K. A., & Syrjänen, S. (2004) · PubMed · Cited by 29
Preneoplastic oral lesions: the clinical value of image cytometry DNA analysis, p53 and p21/WAF1 expression.
Högmo, A., LINDSKOG, S., Lindholm, J., Kuylenstierna, R., Auer, G., & Munck‐Wikland, E. (1998) · PubMed · Cited by 29
Oral cancer and precancerous lesions in 57,518 industrial workers of Gujarat, India.
Smith, L. W., Bhargava, K., Nj, M., Malaowalla, A. M., & Silverman, S. (1975) · PubMed · Cited by 27
Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India
Kumar, P., KANE, S. V., & Rathod, G. P. (2012) · Brazilian Oral Research · doi:10.1590/s1806-83242012000300008 · Cited by 24
Colorimetric analysis of unstained lesions surrounding oral squamous cell carcinomas and oral potentially malignant disorders using iodine
Maeda, K., Suzuki, T., Ooyama, Y., Nakakuki, K., Yamashiro, M., Okada, N., & Amagasa, T. (2009) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2009.11.001 · Cited by 23
Topical inhibition of oral carcinoma cell with polymer delivered celecoxib
Wang, Z., Polavaram, R., & Shapshay, S. M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00272-6 · Cited by 21
Toward Assessing Trends in Oral Mucosal Lesions: Lessons Learned From Oral Cancer
Kleinman, D. V., Swango, P. A., Pindborg, J. J., & Gupta, P. C. (1993) · Advances in Dental Research · doi:10.1177/08959374930070010401 · Cited by 19
Loss of heterozygosity in oral cancer
Kasamatsu, A., Uzawa, K., Usukura, K., Koike, K., Nakashima, D., Ishigami, T., Fushimi, K., Ogawara, K., Shiiba, M., & Tanzawa, H. (2011) · Oral Science International · doi:10.1016/s1348-8643(11)00027-9 · Cited by 19
Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (Muta™Mouse) and the effects of 1,4-phenylenebis(methylene)selenocyanate
von Pressentin, M. D. M., Bayoumy, K. E., & Guttenplan, J. B. (2000) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(00)00005-x · Cited by 18
Screening for oral cancer: contributing to the debate
Warnakulasuriya, S., & Cain, N. (2011) · Journal of Investigative and Clinical Dentistry · doi:10.1111/j.2041-1626.2010.00040.x · Cited by 16
Self-citation
G1 cyclins in oral epithelial dysplasia
Oliver, R., & MacDonald, D. G. (2001) · Journal of Oral Pathology and Medicine · doi:10.1034/j.1600-0714.2001.300203.x · Cited by 15
Feasibility of recruitment to an oral dysplasia trial in the United Kingdom
Nankivell, P., Dunn, J., Langman, M. J. S., & Mehanna, H. M. (2012) · Head & Neck Oncology · doi:10.1186/1758-3284-4-40 · Cited by 13
Effects of 3H-1,2-dithiole-3-thione, 1,4-phenylenebis(methylene)selenocyanate, and selenium-enriched yeast individually and in combination on benzo[a]pyrene-induced mutagenesis in oral tissue and esophagus in lacZ mice
Guttenplan, J. B., Spratt, T. E., Khmelnitsky, M., Kosinska, W., Desai, D. H., & El‐Bayoumy, K. (2004) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2004.02.002 · Cited by 12
Image analysis of p53 and cyclin D1 expression in premalignant lesions of the oral mucosa.
Liu, S. C., Hu, Y., Sauter, E. R., Clapper, M. L., Chen, S. Y., Lanfranchi, H. E., Engstrom, P. F., & Klein–Szanto, A. J. (1999) · PubMed · Cited by 11
Chemoprevention with erlotinib and celecoxib in advanced premalignant lesions of the head and neck: Results of a phase I study.
Saba, N. F., Müller, S., Chen, A. Y., Grist, W., Gibson, K., Nannapaneni, S., Yang, C. S., Khuri, F. R., Chen, Z. G., & Shin, D. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.5535 · Cited by 3
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
Durie, B. G. M., & Salmon, S. E. (1975) · Cancer · doi:10.1002/1097-0142(197509)36:3

Research works printed but not linked: 5

Malaysia DDMoH, 1978, Dental epidemiological survey of adults in Peninsular Malaysia, 98
Mehta FS, 1971, Report on oral cancer and precancerous conditions in Indian rural populations, 1966–1969
Ministry of Health, 2009, National oral health survey, Sri Lanka (2002/2003)
Warnakulasuriya S, 1998, Oral oncology
Gopal Ray J, 2013, Pathogenesis and malignant transformation of oral submucous fibrosis: Possible role of lysly oxidase (lox) and NADPH quinone oxidoreductase 1 (NQO1) gene polymorphis. PhD Thesis

Sorted by citations

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Oral squamous cell carcinomas: state of the field and emerging directions
Tan, Y., Wang, Z., Xu, M., Li, B., Huang, Z., Qin, S., Nice, E. C., Tang, J., & Huang, C. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00249-w · Cited by 988
Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy
Shih, Y.-H., Wang, T., Shieh, T., & Tseng, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122940 · Cited by 290
Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders
Ranganathan, K., & Kavitha, L. (2019) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_13_19 · Cited by 241
Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives
Cristaldi, M., Mauceri, R., Fede, O. D., Giuliana, G., Campisi, G., & Panzarella, V. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01476 · Cited by 202

See all 248

Authors: Dionne, K. R., Warnakulasuriya, S., Binti Zain, R., & Cheong, S. C.
Affiliations: University of Malaya (MY)
King's College London (GB)
Faculty of Dentistry Oral Cancer Research and Co‐ordinating Centre (OCRCC), University of Malaya Kuala Lumpur Malaysia
Corresponding author: Cheong, Sok Ching
ORCID: Dionne, Kalen R.
Warnakulasuriya, Saman
Cheong, Sok Ching
Venue: International Journal of Cancer
Publisher: Wiley
Published: 2014-02-11
Volume: 136
Issue: 3
Pages: 503-515
ISSN: 0020-7136 (ISSN-L)
1097-0215
DOI: 10.1002/ijc.28754
OpenAlex: W2154220394
Cited by: 248
References: 160
Citations by year: 2026: 4 · 2025: 11 · 2024: 17 · 2023: 24 · 2022: 32 · 2021: 29 · 2020: 30 · 2019: 20 · 2018: 17 · 2017: 19 · 2016: 21 · 2015: 17 · 2014: 6
FWCI: 3.53
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: International Journal of Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Dentistry › General Dentistry › Oral Health Pathology and Treatment
Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Health Sciences › Dentistry › General Dentistry › HIV/AIDS oral health manifestations
Keywords: oral potentially malignant disorders, oral squamous cell carcinoma, leukoplakia, erythroplakia, oral submucous fibrosis, chemoprevention, oral cancer screening, early diagnosis, oral carcinogenesis, oral epithelium, in vitro disease model
MeSH terms: Aged, Carcinoma, Squamous Cell, DNA, Humans, Leukoplakia, Oral, Male, Middle Aged, Mouth Neoplasms, Ploidies, Loss of Heterozygosity, Cyclin D1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks